Trials / Completed
CompletedNCT05049408
Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer
Verification of Saliva MMP-1 as a Strong Diagnostic Marker of Oral Cavity Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,160 (actual)
- Sponsor
- S&T Biomed Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The study is designed to measure salivary matrix metalloproteinase-1 (MMP-1) using the enzyme-linked immunosorbent assay (ELISA) we developed previously in patients with oral potentially malignant disorders (OPMD), oral squamous cell carcinoma (OSCC), and healthy participants. The purpose of this study is to evaluate the potential of the newly developed salivary MMP-1 ELISA as an adjunctive tool to aid in diagnosis of OSCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | MMP-1 Enzyme Linked Immunosorbent assay (ELISA) | The MMP-1 ELISA is to measure salivary MMP-1 levels of participants |
Timeline
- Start date
- 2011-02-17
- Primary completion
- 2016-12-07
- Completion
- 2016-12-07
- First posted
- 2021-09-20
- Last updated
- 2021-09-28
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05049408. Inclusion in this directory is not an endorsement.